Literature DB >> 1327754

MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase.

D Stokoe1, D G Campbell, S Nakielny, H Hidaka, S J Leevers, C Marshall, P Cohen.   

Abstract

A novel protein kinase, which was only active when phosphorylated by the mitogen-activated protein kinase (MAP kinase), has been purified 85,000-fold to homogeneity from rabbit skeletal muscle. This MAP kinase activated protein kinase, termed MAPKAP kinase-2, was distinguished from S6 kinase-II (MAPKAP kinase-1) by its response to inhibitors, lack of phosphorylation of S6 peptides and amino acid sequence. MAPKAP kinase-2 phosphorylated glycogen synthase at Ser7 and the equivalent serine (*) in the peptide KKPLNRTLS*VASLPGLamide whose sequence is similar to the N terminus of glycogen synthase. MAPKAP kinase-2 was resolved into two monomeric species of apparent molecular mass 60 and 53 kDa that had similar specific activities and substrate specificities. Peptide sequences of the 60 and 53 kDa species were identical, indicating that they are either closely related isoforms or derived from the same gene. MAP kinase activated the 60 and 53 kDa forms of MAPKAP kinase-2 by phosphorylating the first threonine residue in the sequence VPQTPLHTSR. Furthermore, Mono Q chromatography of extracts from rat phaeochromocytoma and skeletal muscle demonstrated that two MAP kinase isoforms (p42mapk and p44mapk) were the only enzymes in these cells that were capable of reactivating MAPKAP kinase-2. These results indicate that MAP kinase activates at least two distinct protein kinases, suggesting that it represents a point at which the growth factor-stimulated protein kinase cascade bifurcates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327754      PMCID: PMC556909          DOI: 10.1002/j.1460-2075.1992.tb05492.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  47 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II.

Authors:  T W Sturgill; L B Ray; E Erikson; J L Maller
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

3.  The subunit structure of rabbit-skeletal-muscle phosphorylase kinase, and the molecular basis of its activation reactions.

Authors:  P Cohen
Journal:  Eur J Biochem       Date:  1973-04-02

4.  Purification and characterization of a protein kinase from Xenopus eggs highly specific for ribosomal protein S6.

Authors:  E Erikson; J L Maller
Journal:  J Biol Chem       Date:  1986-01-05       Impact factor: 5.157

5.  Demonstration that the leukocyte common antigen CD45 is a protein tyrosine phosphatase.

Authors:  N K Tonks; H Charbonneau; C D Diltz; E H Fischer; K A Walsh
Journal:  Biochemistry       Date:  1988-11-29       Impact factor: 3.162

6.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

7.  Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase and protein kinase C.

Authors:  H Hidaka; M Inagaki; S Kawamoto; Y Sasaki
Journal:  Biochemistry       Date:  1984-10-09       Impact factor: 3.162

8.  ERK1 and ERK2, two microtubule-associated protein 2 kinases, mediate the phosphorylation of tyrosine hydroxylase at serine-31 in situ.

Authors:  J W Haycock; N G Ahn; M H Cobb; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

9.  Primary-structure requirements for inhibition by the heat-stable inhibitor of the cAMP-dependent protein kinase.

Authors:  J D Scott; M B Glaccum; E H Fischer; E G Krebs
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

10.  MAP kinase activator from insulin-stimulated skeletal muscle is a protein threonine/tyrosine kinase.

Authors:  S Nakielny; P Cohen; J Wu; T Sturgill
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

View more
  128 in total

1.  SIMKK, a mitogen-activated protein kinase (MAPK) kinase, is a specific activator of the salt stress-induced MAPK, SIMK.

Authors:  S Kiegerl; F Cardinale; C Siligan; A Gross; E Baudouin; A Liwosz; S Eklöf; S Till; L Bögre; H Hirt; I Meskiene
Journal:  Plant Cell       Date:  2000-11       Impact factor: 11.277

Review 2.  ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions.

Authors:  Philippe P Roux; John Blenis
Journal:  Microbiol Mol Biol Rev       Date:  2004-06       Impact factor: 11.056

3.  Mitogen-activated protein kinase-activated protein kinase 2 in angiotensin II-induced inflammation and hypertension: regulation of oxidative stress.

Authors:  Talin Ebrahimian; Melissa Wei Li; Catherine A Lemarié; Stefania M C Simeone; Patrick J Pagano; Matthias Gaestel; Pierre Paradis; Sven Wassmann; Ernesto L Schiffrin
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

4.  Feedback control of the protein kinase TAK1 by SAPK2a/p38alpha.

Authors:  Peter C F Cheung; David G Campbell; Angel R Nebreda; Philip Cohen
Journal:  EMBO J       Date:  2003-11-03       Impact factor: 11.598

5.  Trophic factor withdrawal: p38 mitogen-activated protein kinase activates NHE1, which induces intracellular alkalinization.

Authors:  A R Khaled; A N Moor; A Li; K Kim; D K Ferris; K Muegge; R J Fisher; L Fliegel; S K Durum
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  A link between MAP kinase and p34(cdc2)/cyclin B during oocyte maturation: p90(rsk) phosphorylates and inactivates the p34(cdc2) inhibitory kinase Myt1.

Authors:  A Palmer; A C Gavin; A R Nebreda
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

7.  Cloning and characterization of p97MAPK, a novel human homolog of rat ERK-3.

Authors:  A X Zhu; Y Zhao; D E Moller; J S Flier
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Stress-induced regulation of eukaryotic elongation factor 2 kinase by SB 203580-sensitive and -insensitive pathways.

Authors:  Axel Knebel; Claire E Haydon; Nick Morrice; Philip Cohen
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

Review 9.  Role of mitogen-activated protein kinases and protein kinase C in regulating low-density lipoprotein receptor expression.

Authors:  Kamal D Mehta
Journal:  Gene Expr       Date:  2002

10.  Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.

Authors:  T W Schulte; M V Blagosklonny; L Romanova; J F Mushinski; B P Monia; J F Johnston; P Nguyen; J Trepel; L M Neckers
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.